LXEO: Gene therapy data, cash runway | Tickers & Tactics cover art

LXEO: Gene therapy data, cash runway | Tickers & Tactics

LXEO: Gene therapy data, cash runway | Tickers & Tactics

Listen for free

View show details

This Season's Biggest Deal | $0.99/mo for 3 months + $20 Audible bonus

Auto-renews at $8.99/mo. after 3 months - terms apply.
Summary
LXEO and the cash runway: Lexeo Therapeutics jumps on gene-therapy data on a deep-red day — Maya and Theo decode LXEO and LX2020's 80% cut in dangerous heart rhythms, the FDA's surrogate-endpoint signal, and do the runway math on $219.1 million of cash against a $38.3 million quarterly loss. Tickers & Tactics is for education and entertainment only and is not financial, investment, or tax advice. Nothing here is a recommendation to buy or sell any security. Options involve substantial risk and are not suitable for all investors. Do your own research or talk to a licensed professional before investing. Episodes are researched and written with AI assistance and voiced by AI hosts (Maya and Theo), produced by Alvin Williams.
No reviews yet
In the spirit of reconciliation, Audible acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respect to their elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.